0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover) Loot Price: R1,742
Discovery Miles 17 420
Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover): K....

Hepatitis C Virus: The Next Epidemic, An issue of Gastroenterology Clinics of North America, Volume 44-4 (Hardcover)

K. Rajender Reddy

Series: The Clinics: Internal Medicine

 (sign in to rate)
Loot Price R1,742 Discovery Miles 17 420 | Repayment Terms: R163 pm x 12*

Bookmark and Share

Expected to ship within 12 - 17 working days

There are over 180 million people with chronic HCV infection worldwide with between 2.7 and 3.9 million in the United States. Hepatitis C most significantly affects Asia and Africa, with rates up to 15% in countries such as Egypt and up to 30% in certain regions such as Punjab, Pakistan. Hepatitis C places a significant burden on the public health infrastructure, as it remains the leading cause of chronic liver disease, accounting for 50-75% of primary liver cancers and is responsible for 30% of all liver transplantations. It is estimated to have cost the United States $5.5 billion in 1997, comparable to the national cost of asthma, $5.8 billion in 1994.This number is only expected to grow as the current HCV population ages, increasing overall rates of compensated cirrhosis/end-stage liver disease. The evolution of directly acting anti-virals has ushered in a new era for chronic hepatitis C. Ongoing drug development strategy has involved targeting several replication steps of the virus and the hope is to see all oral therapies by late 2014 or early 2015. Thus we are at an exciting cross roads with regard to new information and challenges with HCV: rising disease burden with associated high costs, the challenges globally and in multiple patient populations, and the impending availability of effective and well tolerated treatments. Therefore there is a need to commission an exclusive issue of GCNA for HCV.

General

Imprint: Elsevier - Health Sciences Division
Country of origin: United States
Series: The Clinics: Internal Medicine
Release date: December 2015
Authors: K. Rajender Reddy
Format: Hardcover
ISBN-13: 978-0-323-40248-4
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
Promotions
LSN: 0-323-40248-8
Barcode: 9780323402484

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Drug Hepatotoxicity, An Issue of Clinics…
Vinod Rustgi Hardcover R2,201 Discovery Miles 22 010
Advances in Cholestatic Liver Diseases…
Cynthia Levy Hardcover R1,740 Discovery Miles 17 400
Medical Medium Liver Rescue - Answers To…
Anthony William Hardcover  (3)
R765 R597 Discovery Miles 5 970
Hepatotoxicity
Costin Teodor Streba, Ion Rogoveanu, … Hardcover R2,837 Discovery Miles 28 370
Drug-Induced Liver Injury, Volume 85
Anup Ramachandran, Hartmut Jaeschke Hardcover R5,687 Discovery Miles 56 870
Primary Biliary Cholangitis , An Issue…
Binu V John Hardcover R2,094 Discovery Miles 20 940
Liver Cirrhosis - Debates and Current…
Georgios Tsoulfas Hardcover R3,399 Discovery Miles 33 990
Hepatitis A and Other Associated…
Costin Teodor Streba, Cristin Constantin Vere, … Hardcover R3,388 Discovery Miles 33 880
Hepatobiliary Imaging, An Issue of…
Benjamin M. Yeh, Frank H. Miller Hardcover R2,696 Discovery Miles 26 960
Liver Research and Clinical Management
Luis Rodrigo Hardcover R3,426 Discovery Miles 34 260
Liver Pathophysiology - Therapies and…
Pablo Muriel Hardcover R3,837 Discovery Miles 38 370
Nonalcoholic Fatty Liver Disease - An…
Emad Hamdy Gad Hardcover R3,386 Discovery Miles 33 860

See more

Partners